| Title |
Use of calcium hydroxylapatite (Radiesse®) for facial augmentation
|
|---|---|
| Published in |
Clinical Interventions in Aging, March 2008
|
| DOI | 10.2147/cia.s2065 |
| Pubmed ID | |
| Authors |
Patricio F Jacovella |
| Abstract |
Radiesse (Bioform Inc, USA) is a sterile, latex-free, non-pyrogenic, semi-solid, cohesive subdermal, injectable implant, whose principal component is synthetic calcium hydroxylapatite, a biocompatible material with over 20 years of use in medicine. The semi-solid nature of the product is created by suspending calcium hydroxylapatite microspheres of 25-45 microns diameter in a gel carrier of carboxymethylcellulose. The product has FDA approval for esthetic facial augmentation in the US. Such approval includes the long-lasting correction of moderate to severe facial wrinkles and folds and the treatment of facial fat loss due to immunodeficiency virus infection. Diverse facial regions can be injected in order to ameliorate or enhance some features: glabellar lines, subdermal support of the brows, malar and buccal fat pads, tear troughs, nasolabial folds, nose, lips, perioral region, marionette lines, oral commisures and chin among others, as well as saucerized acne scars. Other medical indications include nipple projection for nipple areolar reconstruction, urinary incontinence, vesicoureteral reflux, vocal cord augmentation, and use as a radiographic tissue marker. The average lasting result is from 12 to 18 months. Radiesse can be considered an effective soft-tissue filler for overall longevity, biocompatibility, and low rate of side effects. |
Mendeley readers
The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| United States | 1 | <1% |
| India | 1 | <1% |
| Unknown | 145 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 16 | 11% |
| Researcher | 15 | 10% |
| Other | 14 | 9% |
| Student > Master | 14 | 9% |
| Student > Ph. D. Student | 12 | 8% |
| Other | 31 | 21% |
| Unknown | 46 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 32% |
| Nursing and Health Professions | 6 | 4% |
| Agricultural and Biological Sciences | 6 | 4% |
| Biochemistry, Genetics and Molecular Biology | 6 | 4% |
| Materials Science | 6 | 4% |
| Other | 25 | 17% |
| Unknown | 51 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2022.
All research outputs
#8,535,472
of 25,374,917 outputs
Outputs from Clinical Interventions in Aging
#818
of 1,968 outputs
Outputs of similar age
#33,884
of 95,559 outputs
Outputs of similar age from Clinical Interventions in Aging
#7
of 11 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,968 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,559 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.